The Scope of Big Data in One Medicine: Unprecedented Opportunities and Challenges
Advances in high-throughput molecular biology and electronic health records (EHR), coupled with increasing computer capabilities have resulted in an increased interest in the use of big data in health care. Big data require collection and analysis of data at an unprecedented scale and represents a p...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2017-11-01
|
| Series: | Frontiers in Veterinary Science |
| Subjects: | |
| Online Access: | http://journal.frontiersin.org/article/10.3389/fvets.2017.00194/full |
| _version_ | 1818171765736603648 |
|---|---|
| author | Molly E. McCue Annette M. McCoy |
| author_facet | Molly E. McCue Annette M. McCoy |
| author_sort | Molly E. McCue |
| collection | DOAJ |
| description | Advances in high-throughput molecular biology and electronic health records (EHR), coupled with increasing computer capabilities have resulted in an increased interest in the use of big data in health care. Big data require collection and analysis of data at an unprecedented scale and represents a paradigm shift in health care, offering (1) the capacity to generate new knowledge more quickly than traditional scientific approaches; (2) unbiased collection and analysis of data; and (3) a holistic understanding of biology and pathophysiology. Big data promises more personalized and precision medicine for patients with improved accuracy and earlier diagnosis, and therapy tailored to an individual’s unique combination of genes, environmental risk, and precise disease phenotype. This promise comes from data collected from numerous sources, ranging from molecules to cells, to tissues, to individuals and populations—and the integration of these data into networks that improve understanding of heath and disease. Big data-driven science should play a role in propelling comparative medicine and “one medicine” (i.e., the shared physiology, pathophysiology, and disease risk factors across species) forward. Merging of data from EHR across institutions will give access to patient data on a scale previously unimaginable, allowing for precise phenotype definition and objective evaluation of risk factors and response to therapy. High-throughput molecular data will give insight into previously unexplored molecular pathophysiology and disease etiology. Investigation and integration of big data from a variety of sources will result in stronger parallels drawn at the molecular level between human and animal disease, allow for predictive modeling of infectious disease and identification of key areas of intervention, and facilitate step-changes in our understanding of disease that can make a substantial impact on animal and human health. However, the use of big data comes with significant challenges. Here we explore the scope of “big data,” including its opportunities, its limitations, and what is needed capitalize on big data in one medicine. |
| first_indexed | 2024-12-11T19:01:55Z |
| format | Article |
| id | doaj.art-1c01fc715277472d81963da13d03d964 |
| institution | Directory Open Access Journal |
| issn | 2297-1769 |
| language | English |
| last_indexed | 2024-12-11T19:01:55Z |
| publishDate | 2017-11-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Veterinary Science |
| spelling | doaj.art-1c01fc715277472d81963da13d03d9642022-12-22T00:54:00ZengFrontiers Media S.A.Frontiers in Veterinary Science2297-17692017-11-01410.3389/fvets.2017.00194278019The Scope of Big Data in One Medicine: Unprecedented Opportunities and ChallengesMolly E. McCue0Annette M. McCoy1Equine Genetics and Genomics Laboratory, Veterinary Population Medicine, University of Minnesota, St Paul, MN, United StatesVeterinary Clinical Medicine, University of Illinois Urbana-Champaign, Urbana, IL, United StatesAdvances in high-throughput molecular biology and electronic health records (EHR), coupled with increasing computer capabilities have resulted in an increased interest in the use of big data in health care. Big data require collection and analysis of data at an unprecedented scale and represents a paradigm shift in health care, offering (1) the capacity to generate new knowledge more quickly than traditional scientific approaches; (2) unbiased collection and analysis of data; and (3) a holistic understanding of biology and pathophysiology. Big data promises more personalized and precision medicine for patients with improved accuracy and earlier diagnosis, and therapy tailored to an individual’s unique combination of genes, environmental risk, and precise disease phenotype. This promise comes from data collected from numerous sources, ranging from molecules to cells, to tissues, to individuals and populations—and the integration of these data into networks that improve understanding of heath and disease. Big data-driven science should play a role in propelling comparative medicine and “one medicine” (i.e., the shared physiology, pathophysiology, and disease risk factors across species) forward. Merging of data from EHR across institutions will give access to patient data on a scale previously unimaginable, allowing for precise phenotype definition and objective evaluation of risk factors and response to therapy. High-throughput molecular data will give insight into previously unexplored molecular pathophysiology and disease etiology. Investigation and integration of big data from a variety of sources will result in stronger parallels drawn at the molecular level between human and animal disease, allow for predictive modeling of infectious disease and identification of key areas of intervention, and facilitate step-changes in our understanding of disease that can make a substantial impact on animal and human health. However, the use of big data comes with significant challenges. Here we explore the scope of “big data,” including its opportunities, its limitations, and what is needed capitalize on big data in one medicine.http://journal.frontiersin.org/article/10.3389/fvets.2017.00194/fulldeep phenotypingmultilayer disease modulenetwork medicinebioinformaticsstructural informaticsclinical informatics |
| spellingShingle | Molly E. McCue Annette M. McCoy The Scope of Big Data in One Medicine: Unprecedented Opportunities and Challenges Frontiers in Veterinary Science deep phenotyping multilayer disease module network medicine bioinformatics structural informatics clinical informatics |
| title | The Scope of Big Data in One Medicine: Unprecedented Opportunities and Challenges |
| title_full | The Scope of Big Data in One Medicine: Unprecedented Opportunities and Challenges |
| title_fullStr | The Scope of Big Data in One Medicine: Unprecedented Opportunities and Challenges |
| title_full_unstemmed | The Scope of Big Data in One Medicine: Unprecedented Opportunities and Challenges |
| title_short | The Scope of Big Data in One Medicine: Unprecedented Opportunities and Challenges |
| title_sort | scope of big data in one medicine unprecedented opportunities and challenges |
| topic | deep phenotyping multilayer disease module network medicine bioinformatics structural informatics clinical informatics |
| url | http://journal.frontiersin.org/article/10.3389/fvets.2017.00194/full |
| work_keys_str_mv | AT mollyemccue thescopeofbigdatainonemedicineunprecedentedopportunitiesandchallenges AT annettemmccoy thescopeofbigdatainonemedicineunprecedentedopportunitiesandchallenges AT mollyemccue scopeofbigdatainonemedicineunprecedentedopportunitiesandchallenges AT annettemmccoy scopeofbigdatainonemedicineunprecedentedopportunitiesandchallenges |